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Abstract
Background: Several studies have reported a correlation between antral follicle count by conventional 2D
transvaginal sonography and serum anti-Müllerian hormone levels. However, few studies have investigated the
effectiveness of 3D SonoAVC transvaginal ultrasound technology, particularly in infertile women. Therefore, this
study aims to evaluate the usefulness of three-dimensional (3D) SonoAVC transvaginal ultrasound technology for
antral follicle count and its correlation to conventional two-dimensional (2D) transvaginal ultrasound and serum
levels of anti-Müllerian hormone in infertile women.
Methods: This cross-sectional study included 42 infertile women with age lower than 40 years that underwent
treatment at a private fertility clinic between June and December 2015. Patient data included age, body mass index
and cause of infertility. On cycle day 3 the following hormone levels were measured: serum levels of anti-Müllerian
hormone, follicle-stimulating hormone, cancer antigen 125, prolactin, thyroid-stimulating hormone and oestradiol;
the number of antral follicles was counted as well. The scanning were performed through 2D and 3D technology
transvaginal ultrasound.
Results: Using a Bland-Altman test we demonstrated that both technologies are quite equivalent. However, antral
follicle count is higher using 3D ultrasound technology compared to 2D technology (p < 0.001; Wilcoxon test), this
finding is mainly remarkable in ovaries with more than 20 antral follicles. Moreover, the mean time required for
manual 2D ultrasound and 3D SonoAVC measurements were 275 ± 109 and 103 ± 57 s, respectively (p < 0.001).
Serum AMH concentration correlated to the total number of early antral follicles (correlation coefficients = 0.678
and 0.612; p < 0.001 by 2D ultrasound and 3D SonoAVC, respectively; Spearman’s correlation test).
Conclusions: Antral follicle count is better estimated using 3D ultrasound compared to 2D technology. A great
advantage of 3D SonoAVC was less time required for an examination and the visual advantage when it need to
count more than 20 follicles.
Trial registration: CAAE: 35141114.4.0000.5327. Registered 10 June 2015.
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Background
One of the biggest challenges in the management of in-
fertile patients is the loss of reproductive potential with
increasing age. The postponement of pregnancy in the
modern world is due to several factors, including the
pursuit of careers by women, widespread use of contra-
ception, and the development of assisted reproduction
techniques. Maternal age is a major factor for decrease
in fertility and increase in abortion rates [1–3]. De-
creased ovarian reserve with the loss of oocyte quality
and depletion of the number of available oocytes with
increased age is reflected in the decline in oocyte recov-
ery rate and the decrease in embryo quality and preg-
nancy rates by in vitro fertilization [1, 2]. The use of
follicle - stimulating hormone (FSH), oestradiol (E2), in-
hibin B, and, more recently, anti-Müllerian hormone
(AMH) to evaluate reproductive potential have been de-
scribed as good markers [4].
Antral follicle count (AFC) has been assessed by two-
dimensional (2D) transvaginal ultrasound for several
years with good resolution and accuracy. Some authors
evaluated the applicability of three-dimensional (3D)
technology in comparison with conventional 2D ultra-
sound to assess the accuracy of this new image manage-
ment software and did not find any advantage [5].
Furthermore, recently, some authors validated a new
mathematical tool to predict ovarian age, using some
hormonal and ultrasonographic parameters. Using mul-
tiplanar and inversion mode 3D, they showed that AFC
is a reliable marker for ovarian reserve, but did not com-
pared to 2D; in addition, the sample was composed
mainly by fertile patients [6].
Although few studies had evaluated this new technol-
ogy in infertile women, there is a need for consensus on
a parameter of follicle diameter that represents ovarian
functional’s reserve and the usefulness of this emerging
technology (3D) compared to 2D. There is also the need
to analyze these two different technologies along with
serum AMH levels to evaluate ovarian reserve. In this
context, it is imperative to evaluate and validate new im-
aging tools, such as 3D SonoAVC, to explore its poten-
tial and define its liabilities.
Therefore, the aim of this study was to identify the
agreement between AFCs measured by transvaginal
ultrasound (2D and 3D SonoAVC) and serum AMH
levels in infertile women.
Methods
Study population and design
The Strengthening the Reporting of Observational Stud-
ies in Epidemiology guidelines for observational studies
was employed in this cross-sectional study of 42 infertile
women who underwent treatment at the Department of
Obstetrics and Gynecology of Hospital de Clínicas de
Porto Alegre or the Insemine Center for Human
Reproduction (Porto Alegre, Brazil).
The inclusion criteria were body mass index <30 kg/m2,
age between 25 and 40 years old, presence of both ovaries,
not currently on hormone therapy and no history of
chemo and/or radiotherapy. Carrier infertility, which is
characterized as the inability to achieve conception or
bring a conception to term after a year or more of regular
sexual intercourse without contraceptive protection, was
also an inclusion criteria.
Exclusion criteria were follicle diameter > 10 mm in
both ovaries, ovarian cysts ≥3.0 cm, the presence of
endometrioma, injury and/or ovarian masses, the pres-
ence of a corpus luteum and/or hemorrhagic cyst body
and a history of oophorectomy and/or partial ovarian
cystectomy.
Study protocol
Patients were evaluated at the beginning of the men-
strual cycle (days 3–4) by transvaginal ultrasound at the
Insemine Center for Human Reproduction using the
Voluson E8 Expert ultrasound system (GE Medical
Systems, Chicago, IL, USA). The ultrasounds techniques’
data were obtained by the same researcher and were per-
formed in the same day with twenty minutes of interval
between both of them. Blood samples were collected for
hormonal measurements.
Hormonal measurements
Serum AMH levels were determined using an ultra-
sensitive enzyme-linked immunosorbent assay (sensi-
tivity, <0.02–10.4 ng/mL; Beckman Coulter, Inc., Brea,
CA, USA).
Serum levels of E2 and FSH (Siemens Om-MA Immu-
lite 2000, Munich, Germany) were determined using a
chemiluminescence immunoassay. The range of detec-
tion of the immunoassay were 10.7 ng/ml–3000 pg/ml
for E2 and 0.3–200 mUI/ml for FSH.
Transvaginal ultrasound
All patients were examined by the same researcher
and had both ovaries analyzed. The ultrasounds’ tech-
niques were performed at the beginning of the men-
strual cycle using the Voluson E8 Expert ultrasound
system (GE Medical Systems, Chicago, IL, USA)
equipped with a volumetric transvaginal transducer to
count the number of antral follicles and determine
the volume of each antral follicle. Ovarian volume
was calculated based on diameter using the formula
length × width × depth × 0.523.
Ultrasound’s settings for data acquisition were stan-
dardized for all subjects as follows: transducer frequency,
7.5 MHz; gain, −5; enhance, 2; speckle reduction image,
2; reject level, 25; and harmonic, high.
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Measurement 1: 2D ultrasound image
The number of follicles in two planes, longitudinal and
transverse, was determined and the average diameter
was calculated. The antral follicle size was determined
by two perpendicular diameters (Fig. 1).
Measurement 2: 3D SonoAVC
The number of follicles in 3D was measured using the
software, and the volume of each follicle was automatic-
ally calculated based on the anechoic intrafollicular areas
in the scanner (Fig. 2). The device was set to analyze
only the region of interest with no extra-ovarian struc-
tures. The follicular images were displayed with the re-
spective measurements and volumes. Post-processing of
the images was manually performed when needed, such
as AFCs that were not included in the automatic analysis
and the exclusion of adjacent structures. The time spent
to perform the follicle count by 2D and 3D SonoAVC
were compared.
The same investigator performed all ultrasounds with-
out knowledge of previous 2D or 3D results.
Statistical analysis
Statistical analysis was performed using SPSS version
22.0 software (IBM-SPSS, Inc., Chicago, IL, USA). The
distribution of the variables were analysed through
Shapiro-Wilk distribution test. Data that presented para-
metric distribution were described as mean ± standard
deviation (SD), and those with non-parametric distribu-
tion were described as median [percentile 25-percentile
75]. Paired t-test or Wilcoxon’s signed-rank test were
performed according to the variables, parametric or
non-parametric, these tests were performed due to sam-
ple’s characteristics; they are dependent observations.
For establishing agreement between the two ultrasound
methods, Bland-Altman analysis was used [7]. Statistical
significance were considered when p value <0.05.
An institutional ethics committee approved this research
project (IRB equivalent, # CAAE: 35,141,114.4.0000.5327).
Results
The results regarding the women that underwent the
study are presented in the Table 1. The causes of infertil-
ity found in this study were sterility without apparent
cause (n = 8), anatomical factors (n = 11), hormonal fac-
tors (n = 1), endometriosis (n = 11), polycystic ovarian
syndrome (PCOS; n = 6), ovarian factors (n = 3) and male
factors (2). Considering that 42 women represent 100%
that were studied, the causes of infertility represent
Fig. 1 2D ultrasound image to determine antral follicular count.
Legend: Ultrasound image by 2D conventional technique that
allows the observer to count the number of antral follicles as well as
determine its size and volume by length × width × depth × 0.523
Fig. 2 3D ultrasound’s image to determine antral follicle count. Legend:
Ultrasound image by 3D SonoAVC’s technique that allows counting the
number of antral follicles by individual colors determined by the
software. Their volume can also be determined based on the anechoic
intrafollicular areas in the scanner that is automatically calculated
Table 1 Characterization of women that underwent the study
Variables Results p value*
Age (years) 33.00[29.75–37.0] 0.049







Oestradiol level (pg/mL) 45.94 ± 16.81 0.914
Legend: Characterization of the women that participated in the study. *p value
regarding Shapiro-Wilk for variables’ distribution, the ones with non-
parametric distribution are presented as median[P25-P75] and those with
parametric distribution are presented as mean ± SD
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19.0%, 26.2%, 2.4%, 26.2%, 14.3%, 7.1% and 4.8%,
respectively.
The same researcher performed both ultrasounds’
techniques, therefore intra-observer correlation was
calculated at 0.68 (0.942–0.983) through Spearman’s
correlation test. Measurements from the left, right and
both ovaries were considered to perform volume
analysis. The mean volume of left ovary follicles was
7.46 ± 3.90 for 2D US and 7.18 ± 3.75 for 3D. For the
right ovary follicles volume, the mean was 7.18 ± 3.80
and 7.06 and 3.76 for 2D and 3D ultrasounds, respect-
ively. Considering the total volume (left and right
ovaries), the mean for 2D US was 7.28 ± 3.50 and the
mean for 3D US was 7.10 ± 3.54 (Fig. 3). When compar-
ing the two ultrasounds’ techniques and the follicular
volume, there is no statistical difference (p ≥ 0.05; p ≥
0.05; p ≥ 0.05 for left, right and both ovaries, respect-
ively) (Fig. 4).
When comparing both ultrasounds’ techniques regard-
ing AFC, there was statistical difference in left and right
ovaries. This data characteristic can also be verified
when comparing 2D and 3D techniques and AFC re-
garding the total AFC, which is represented as mean
from both ovaries. The median of total AFC was 13.50
with 10.00 and 21.25 as percentile 25 and 75,
respectively for 2D ultrasound. Considering 3D tech-
nique, the median number of total antral follicle count
was 14.50 with 10.00 and 22.00 as 25 and 75 percentiles
respectively, showing statistical difference between both
ultrasounds’ techniques. According to Wilcoxon’s signed-
rank test, the 3D ultrasound AFC was significantly higher
than 2D ultrasound (p < 0.001) (Fig. 5). The agreement be-
tween both ultrasounds’ techniques regarding AFCs can
be found in Fig. 6. The mean time taken to perform
manual 2D ultrasound was significantly longer than that
taken to perform 3D SonoAVC (275 ± 109 and 103 ± 57 s,
respectively; p < 0.05; Mann Whitney’s test).
The results presented no correlation between s-AMH
levels and BMI (p ≥ 0.05). The absence of correlation
was observed between AFC and BMI comparing 2D and
3D techniques (p ≥ 0.05, for 2D and 3D US; Spearman’s
correlation test).
Serum AMH concentration correlated to the total
number of early antral follicles (correlation coeffi-
cients = 0.678 and 0.612; p < 0.001 by 2D ultrasound
and 3D SonoAVC, respectively; Spearman’s correl-
ation test).
Ovarian volume correlated to serum AMH concentra-
tion (correlation coefficient = 0.558; p < 0.001 for 2D US
and correlation coefficient = 0.569; p < 0.001 for 3D US).
Considering only follicles with less than 6 mm, they cor-
relate to s-AMH levels (correlation coefficients = 0.537
and 0.510; p < 0.001 for 2D and 3D ultrasounds).
Discussion
The aim of this study was to identify the agreement be-
tween AFCs through two ultrasounds’ techniques in in-
fertile women. This study evaluated the results obtained
by 2D conventional ultrasound and 3D SonoAVC ultra-
sound performed in 42 infertile women.
The study concluded that 3D technology can measure
more follicles than 2D, this is particularly important and
relevant in ovaries with more than 20 follicles. The bet-
ter estimation of AFCs by 3D ultrasound was also de-
tected by others investigators, regarding a different
group of patients like obese PCOS patients [8]. Weenen
et al. also demonstrated that 3D technology was more
accurate than 2D when ovaries were submitted to histo-
logical confirmation [9].
Our findings are important and opens a new discus-
sion concerning the usefulness of this new technology.
We suggest a clinical trial to study ovarian hyperstimula-
tion syndrome (OHSS) and the 3DSonoAVC technique.
The 3D ultrasound could be implemented even during
infertility investigation, as it is the first step for planning
treatment. The fact that AFC was higher using 3D ultra-
sound did not invalidate 2D technology, both were well
correlated to serum AMH levels. However, in high risk
patients, such as patients that present PCOS, we should
Fig. 3 Comparison between 2D and 3D ultrasounds’ techniques
regarding follicular volume of left, right and both ovaries. Legend:
Analysis of follicular volume in left, right and both ovaries comparing
two ultrasounds’ techniques. Left ovary presented mean of 7.46 ± 3.90
and 7.18 ± 3.75 when comparing 2D and 3D ultrasounds’ techniques,
respectively. Right ovary presented mean of 7.18 ± 3.80 for 2D
ultrasound and 7.06 ± 3.76 for 3D ultrasound. Total follicular volume
was obtained through the sum of left and right volume, for 2D and 3D
ultrasounds’ techniques, the mean was 7.28 ± 3.50 and 7.10 ± 3.54,
respectively. Results are presented as mean bars and standard
deviation error bars. Statistical analysis performed through paired t-test
has demonstrated no difference between the analysis (p≥ 0.05 for the
analysis of left, right and both ovaries)
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rethink the role of 2D. The positive correlation of AFC
to serum AMH and a negative correlation to age ob-
served in our study agree with those of previous studies.
There are both advantages and disadvantages of 3D
SonoAVC technology when compared with 2D ultra-
sound. In traditional 2D follicle count, it is harder to
correctly determine the number of follicles when they
are presented in a large number, which could lead to
over or underestimate follicles count, as described in
previous studies [10, 11]. In 3D SonoAVC technology,
AFC is performed automatically in a few seconds; the
program recognizes anechoic areas of the follicles. The
follicular diameter is plotted on three axes (x, y and z)
and the follicular volume is calculated automatically,
which saves considerable time in routine patient
evaluation and increases the quality of the measures.
However, these same measures can be performed by
conventional 2D ultrasound. The downside of this new
3D SonoAVC technology is the equipment’s higher cost
and the need for specialized training for correctly cap-
ture 3D images from the ovaries.
Furthermore, in 3D SonoAVC, the ovary must be ap-
propriately placed in the region of interest to prevent
the addition of vessels and/or other extraovarian pelvic
structures, such as iliac vessels, hydrosalpinx, and
Morgagni hydatids. This structures could affect the
accuracy and result in under or overestimation of AFC,
depending on the experience of the operator and appro-
priate interpretation of the obtained images. Neverthe-
less, the automatic image capture process must be
evaluated and repeated if considered unsatisfactory
[12].Previous studies have reported a good correlation
between the results obtained by inter and intra-observer
methods [13]. In this study, the same researcher, using
the same technique and settings, captured all images
and the intra-observer correlation was calculated.
A benefit of 3D SonoAVC observed in this study was
the ease of quickly obtaining reproducible measure-
ments, particularly for small follicles. However, after
image capture, the examiner must assess image quality
and verify if the automatic count matches expectations.
This software’s characteristics can improve performance
and workflow in fertility clinics where the number of fol-
licles to be measured is sometimes numerous.
Another interesting possibility of this new technology
is the ability to store images in a 3D virtual block for
Fig. 4 Bland-Altman plot comparing agreement between two ultrasounds’ techniques regarding follicular volume. Legend: Agreement between
2D and 3D ultrasounds’ techniques regarding the mean of follicular volume. The lower (−2.78) and upper (2.41) limits of agreements are
represented as dotted lines, the formula to obtain them are found in the right side of the image (SD stands for Standard Deviation); the mean
difference (−0.18) is represented as a continuous line. Statistical analysis performed through Bland-Altman (p≥ 0.05; paired t-test)
Fig. 5 Comparison between two ultrasounds’ techniques regarding
left, right and both ovaries antral follicle count. Legend: Antral
follicle count performed in both ovaries comparing two ultrasounds’
techniques. The median obtained for 2D and 3D ultrasounds were
13,50[10,00–21,50] and 14,50[10,00–22,00], respectively. Results are
presented as median bars and 25–75 percentile error bars. Box
signed with (*) represent the statistical significance p < 0.001 for total
both ovaries analysis, performed through Wilcoxon’s test
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further detailed studies in case of special interest or to cre-
ate a research database. The future prospects of research
in this field are promising with the advent of new equip-
ment and image management’s technologies to enhance
the knowledge of ovarian folliculogenesis, particularly for
AFCs when the follicle diameter is less than 2 mm.
The main limitation about our results was the fact that
we cannot certify the accuracy of both methods using hist-
ology, Deb et al., 2010, already discussed this. Also, the
exclusion of obese patients (BMI > 30 kg/m2) could be seen
as conservative bias in favor to 2D technology. We con-
ducted AFCs in the initial menstrual cycle’s phase to
minimize the effect of intracycle variation of follicular
diameters and avoid inclusion of ovarian cysts or a pre-
existing corpus luteum, which were considered in the
exclusion criteria in this population. The measurements
performed by the same researcher in both ultrasounds’
techniques were obtained with twenty minutes of interval
between them. Although we tried to minimize the bias, this
observation could be assessed as one weakness of the study.
Conclusions
In conclusion, the results of this study suggest that 3D
SonoAVC can estimate AFCs better when compared to
2D ultrasound, mainly because it can capture images of
ovaries with more than 20 follicles, resulting in a more
reliable counting and was found to be faster than 2D for
AFC. In addition, AFCs by both technologies presented
a positive correlation to serum AMH levels.
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